Neurological symptoms in patient with COVID-19: a case report

Case Report

American Journal of BioMedicine
Volume 10, Issue 4, December 24 2022, Pages 185-192 |

Xinxin Cao1*, Zunyou Wang

Received  June 04 2022   Revised  September 28 2022   Accepted  October 30 2022   Published  December 24 2022



Most children with COVID‐19 show few symptoms and have a mild form of the disease; some pediatrician reported the extra‐pulmonary manifestations in acute COVID‐19 like, neurological and cognitive symptoms with minor instances seizures. However, it has become clear that a small proportion of children need intensive care and it can be very debilitating and lead to long school absences. Our case study report 2.3-year-old child male with head ache with fit and cognitive symptoms, on examination had generalized fatigue, neck stiffness and fever for two days. He had never been to any foreign countries. The specific SARS-CoV-2 RNA was not detected in the nasopharyngeal swab but found in CSF exam without any other finding. A brain MRI showed bilateral front-temporal hypo-perfusion. Neurological manifestations are common and psychosocial stress might lead to clinical neuropsychiatric manifestation. Psychosis may be secondary to viral illness; treatment provided and increased psychosocial stress during pandemics. Improved attention to the possible neuropsychiatric consequences of SARS-CoV-2 viral infection might aid in early identification and better management.

Keywords: COVID‐19; Psychosocial stress; Cognitive symptoms

Copyright © 2022 Xinxin Cao, et al. This article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to citeReferencesDownload citationStatistics
The citation data is computed by the following citation measuring services:

Hidden content
Hidden content
Hidden content
Hidden content
Hidden content
Hidden content
Hidden content
Hidden content

  1. Zhu N, Zhang D, Wang W. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8):727-733.
  2. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis 2020; 94:55-58.
  3. Carfì A, Bernabei R, Landi F. For the Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. J Am Med Assoc 2020; 324(6):603-605.
  4. Liu X, Zhou H, Zhou Y. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect 2020; 81(1):e95-e97.
  5. Needham EJ, Chou SH, Coles AJ, Menon DK. Neurological implications of COVID-19 infections. Neurocrit. Care 2020:1-5.
  6. Zhou F, Yu T, du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229):1054-1062.
  7. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020; 19(5):383-384.
  8. Ueda N, Umetsu R, Abe J, Kato Y, Nakayama Y, Kato Z. Analysis of neuropsychiatric adverse events in patients treated with oseltamivir in spontaneous adverse event reports. Biol. Pharm. Bull 2015; 38(10):1638-1644.
  9. Severance EG, Dickerson FB, Viscidi RP, Bossis I, Stallings CR, Origoni AE. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr. Bull 2011; 37(1):101-107.
  10.  Kotfis K, Williams Roberson S, Wilson JE, et al. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit. Care 2020; 24(1):176.
  11. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol 2004; 203(2):631-637.
  12. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020; 12(3):e7352.
  13. Desforges M, Le Coupanec A, Stodola J, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res 2014; 194:145-158.
  14. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224):565-574.
  15. Raj VS, Osterhaus AD, Fouchier RA, Haagmans BL. MERS: emergence of a novel human coronavirus. Curr Opin Virol 2014; 5:58-62.
  16. Conceição MS, Chetterje MD, Gupta M. Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis. Muthanna medical journal 2022; 9:57-67.
  17. Yousif NG. Mortality rate in cancer patients with COVID-19: meta-analysis data. American Journal of BioMedicine 2021; 9(3):156-163.
  18. Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med 2021; 27:1607-1613.
  19. Sentongo AE, Voleti N. et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: A systematic review and meta-analysis. BMC Infect. Dis 2022; 22:439.
  20. Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA 2022; 328:676-678.
  21. Nehme M, Braillard O, Salamun J, Jacquerioz F, Courvoisier DS, Spechbach H, Guessous I. Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2. J. Gen. Intern. Med 2022; 37:1585-1588.
  22. Meza-Torres B, Delanerolle G, Okusi C, et al. Differences in clinical presentation with long COVID following community and hospital infection, and associations with all-cause mortality: English sentinel network database study (Preprint) JMIR Public Health Surveill 2022; 8:e37668.
  23. Hajjaji N, Lepoutre K, Lakhdar S, et al. 16 Months Follow Up of Patients' Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic. Front. Oncol 2022; 12:901426.
  24. Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: A systematic review and meta-analysis. Infect. Dis. Poverty 2021; 10:132.
  25. Jacobs LG, Paleoudis EG, Bari DL-D, Nyirenda T, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE 2020; 15:e0243882.

1. Access through OpenAthens

2. PDF     XML

For any technique error please contact us.


      PDF           XML

How to cite this article
Cao X, Wang Z. Neurological symptoms in patient with COVID-19: a case report. American Journal of BioMedicine. 2022; 10(4):185-192

Article metric